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Abstract  
Background: Evaluations of complex interventions in public health are frequently undermined 
by problems that can be identified before the effectiveness study stage. Exploratory studies, 
often termed pilot and feasibility studies, are a key step in assessing the feasibility and value 
of progressing to an effectiveness study. Such studies can provide vital information to support 
more robust evaluations, thereby reducing costs and minimising potential harms of the 
intervention. This systematic review forms the first phase of a wider project to address the 
need for stand-alone guidance for public health researchers on designing and conducting 
exploratory studies. The review objectives were to identify and examine existing 
recommendations concerning: when such studies should be undertaken, questions they 
should answer, suitable methods, criteria for deciding whether to progress to an 
effectiveness study, and appropriate reporting. Methods:  We searched for published and 
unpublished guidance reported between January 2000 and November 2016 via bibliographic 
databases, websites, citation tracking and expert recommendations. Included papers were 
thematically synthesized.  Results: The search retrieved 4,095 unique records. 30 papers were 
included, representing 25 unique sources of guidance/recommendations. Eight themes were 
identified: pre-requisites for conducting an exploratory study, nomenclature, guidance for 
intervention assessment, guidance surrounding any future evaluation study design, flexible 
versus fixed design, progression criteria to a future evaluation study, stakeholder involvement 
and reporting of exploratory studies. Exploratory studies were described as being concerned 
with the intervention content, the future evaluation design, or both. However, the 
nomenclature and endorsed methods underpinning these aims were inconsistent across 
papers. There was little guidance on what should precede or follow an exploratory study and 
decision making surrounding this. Conclusions: Existing recommendations are inconsistent 
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concerning the aims, designs and conduct of exploratory studies and guidance is lacking on 
the evidence needed to inform when to proceed to an effectiveness study. 
 
Registration: PROSPERO 2016:CRD42016047843 
Keywords: public health, complex interventions, exploratory studies, research methods, study 
design, pilot study, feasibility study 
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BACKGROUND 
Improving public health, and disrupting complex problems such as smoking, obesity and 
mental health, requires complex, often multilevel, interventions. Such interventions are often 
costly and may cause unanticipated harms, and therefore require evaluation using the most 
robust methods available. However, pressure to identify effective interventions can lead to 
premature commissioning of large effectiveness studies of poorly developed interventions, 
wasting finite research resources [1-3]. In the development of pharmaceutical drugs over 80% 
fail to reaĐh ͚Phase III͛ effeĐtiǀeŶess trials, eǀeŶ after ĐoŶsideraďle iŶǀestŵeŶt [4]. With public 
health interventions, the historical tendency to rush to full evaluation has in some cases led 
to evaluation failures due to issues which could have been identified at an earlier stage, such 
as difficulties recruiting sufficient participants [5].  There is growing consensus that improving 
the effectiveness of public health interventions relies on attention to their design and 
feasibility [3, 28]. However, what constitutes good practice when deciding when a full 
evaluation is warranted, what uncertainties should be addressed to inform this decision and 
how, is unclear. This systematic review aims to synthesize existing sources of guidance for 
͚eǆploratorǇ studies͛ ǁhiĐh ǁe broadly define as studies intended to generate evidence 
needed to decide whether and how to proceed with a full scale effectiveness study. They do 
this by optimising or assessing the feasibility of the intervention and/or evaluation design that 
the effectiveness study would use. Hence, our definition includes studies variously referred to 
throughout the literature as ͚pilot studies͛, ͚feasiďilitǇ studies͛ or, ͚eǆploratorǇ trials͛. Our 
definition is consistent with previous work conducted by Eldridge et al [17, 18], who define 
feasiďilitǇ as aŶ oǀerarĐhiŶg ĐoŶĐept [ϭϴ] ǁhiĐh assesses; ͞… whether the future trial can be 
doŶe, should ďe doŶe, aŶd, if so, hoǁ͟ ;pg. ϮͿ[ϭϳ]. However, our definition also includes 
exploratory studies to inform non-randomised evaluations, rather than a sole focus on trials.    
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The importance of thoroughly establishing the feasibility of intervention and evaluation plans 
prior to embarking on an expensive, fully powered evaluation was indicated in the Medical 
‘esearĐh CouŶĐil͛s ;M‘CͿ fraŵeǁork for the deǀelopŵeŶt aŶd eǀaluatioŶ of complex 
interventions to improve health [6, 7]. This has triggered shifts in the practice of researchers 
and funders towards seeking and granting funding for an ever growing number of studies to 
address feasibility issues. Such studies are however in themselves often expensive [8, 9]. 
While there is a compelling case for such studies, the extent to which this substantial 
investment in exploratory studies has to date improved the effectiveness and cost 
effectiveness of evidence production remains to be firmly established. Where exploratory 
studies are conducted poorly, this investment may simply lead to expenditure of large 
amounts of additional puďliĐ ŵoŶeǇ, aŶd seǀeral Ǉears͛ delaǇ iŶ gettiŶg eǀideŶĐe iŶto the 
hands of decision-makers, without necessarily increasing the likelihood that a future 
evaluation will provide useful evidence. 
 
The ϮϬϬϬ M‘C guidaŶĐe used the terŵ ͚exploratory trial͛ for ǁork ĐoŶduĐted prior to a 
͚definitive trial͛, indicating that it should primarily address issues concerning the optimisation, 
acceptability and delivery of the intervention [10]. This included: adaptation of the 
intervention, consideration of variants of the intervention, testing and refinement of delivery 
method or content, assessment of learning curves and implementation strategies, and 
determining the counterfactual. Other possible purposes of exploratory trials included 
preliminary assessment of effect size in order to calculate the sample size for the main trial, 
and other trial design parameters, including methods of recruitment, randomisation and 
follow up. Updated MRC guidance in 2008 moved away from the sole focus on RCTs 
(randomised controlled trial) of its predecessor reflecting recognition that not all 
interventions can be tested using an RCT, and that the next most robust methods may 
sometimes be the best available option [7, 11]. Guidance for exploratory studies prior to a full 
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evaluation have, however, often been framed as relevant only where the main evaluation is 
to be an RCT [10, 12]. 
 
However, the goals of exploratory studies advocated by research funders has to date varied 
substantially. For instance, the National Institute for Health Research Evaluation Trials and 
Studies Coordinating Centre (NETSCC) definitions of feasibility and pilot studies do not include 
examination of intervention design, delivery or acceptability, and do not suggest that 
modifications to the intervention prior to full scale evaluation will arise from these phases. 
However, the NIHR (National Institute of Health Research) portfolio of funded studies 
iŶdiĐates ǀarious uses of terŵs suĐh as ͚feasiďilitǇ trial͛, ͚pilot trial͛ aŶd ͚eǆploratorǇ trial͛ to 
describe studies with similar aims, while it is rare for such studies not to include a focus on 
intervention parameters [13-15]. Within the research literature there is considerable 
divergence over what exploratory studies should be called, what they should achieve, what 
they should entail, whether and how they should determine progression to future studies, 
and how they should be reported [16-20]. 
 
This paper presents a systematic review of the existing recommendations and guidance on 
exploratory studies relevant to public health, conducted as the first stage of a project to 
develop new MRC guidance on exploratory studies.  This review aims to produce a synthesis 
of current guidance/recommendations in relation to the definition, purpose and content of 
eǆploratorǇ studies, aŶd ǁhat is seeŶ as ͚good͛ aŶd ͚ďad͛ praĐtiĐe as preseŶted ďǇ the 
authors. It will provide an overview of key gaps, and areas in which there is inconsistency 
within and between documents. The rationale for guidance and recommendations are 
presented, as well as the theoretical perspectives informing them. In particular, we examine 
how far the existing recommendations answer the following questions: 
 When is it appropriate to conduct an exploratory study? 
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 What questions should such studies address? 
 What are the key methodological considerations in answering these questions? 
 What criteria should inform a decision on whether to progress to an effectiveness 
study? 
 How should exploratory studies be reported? 
 
METHODS 
This review is reported in accordance with the PRISMA (Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses) statement [21] as evidenced in the PRISMA checklist 
(see Table 1). The review protocol is registered on PROSPERO (registration number: 
CRD42016047843; www.crd.york.ac.uk/prospero). 
Literature search 
A comprehensive search (see Appendix) was designed and completed during August to 
November 2016 to identify published and grey literature reported between January 2000 and 
November 2016 that contained guidance and recommendations on exploratory studies that 
could have potential relevance to public health. Bibliographic databases were: CINAHL; 
Embase; Medline, Medline-In-process; PsycINFO; Web of Science; and PubMed. 
Supplementary searches included key websites (see Appendix), forward and backward 
citation tracking of included papers, as well as contacting experts in the field. The first MRC 
guidance on developing and evaluating complex Interventions in health was published in 
2000, we therefore excluded guidance published before this year. 
Selection of included papers 
Search results were exported into reference management software Endnote, and clearly 
irrelevant or duplicate records removed by an information specialist. Eligibility criteria were 
applied to abstracts and potentially relevant full-text papers by two reviewers working 
independently in duplicate (BH, JS). Discrepancies were agreed by consensus or by a third 
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reviewer if necessary. Full criteria are shown in Table 2. During screening of eligible studies it 
became evident that determining whether or not guidance was applicable to public health 
was not always clear. The criteria  in Table 2 were agreed by the team after a list of 
potentially eligible publications were identified.  
 
 
Table 2: Eligibility criteria for selecting papers 
 Eligibility Criteria 
Definition of 
Exploratory 
study   
 
 A study which aims to generate the evidence needed to decide whether and 
how to proceed with a full scale effectiveness trial, or other study design and 
are labelled as exploratory/pilot/feasibility/phase II/ proof of concept. Eligible 
publications may concern some or all of the design features of exploratory 
studies   
Nature of 
guidance 
 
 Guidance on the purpose, design, implementation or reporting of exploratory 
studies  
and/or  Other puďliĐatioŶ that reports ͚suďstaŶtiǀe iŶforŵatioŶ͛ ĐoŶĐerŶiŶg the 
conduct of exploratory studies within public health - e.g. worked examples 
and methodological papers 
Applicability 
to public 
health  
 Public health audiences clearly among intended users of the guidance 
(authors are from Public Health departments, cites literature from public 
health journals, provides public health examples or uses the terŵ ͚puďliĐ 
health͛ or ǀariaŶts of this, e.g. ͚preǀeŶtioŶ sĐieŶĐe͛ 
 or  Unspecific audience but of plausible relevance to public health (might, for 
example, include either an author from a public health research department 
or a citation to a public health journal) 
Publication 
Type/ 
Source 
Book, book chapter, journal article, report or readily available doctoral thesis, 
funding organisation websites (UK and non-UK based) 
 
Date & 
language 
restrictions 
Publications reported since 2000 to date (November 2016), in any language. 
 
Quality assessment of included papers 
Given the nature of publications included (expert guidance or methodological discussion 
papers) quality assessment was not applicable.   
Data extraction and thematic synthesis 
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A thematic synthesis of guidance within included documents was performed [22]. This 
involved the use of an a priori coding framework (based on the projects aims and objectives), 
developed by RT, JS and DW [23, see Appendix]. Data were extracted using this schema in 
qualitative analytic software NVivo by one reviewer (BH). A 10% sample of coded papers was 
checked by a second reviewer (JS). Data were then conceptualised into final themes by 
agreement (BH, JS, DW, RT).  
RESULTS 
Review statistics 
4,095 unique records were identified of which 93 were reviewed in full text (see Figure 1). In 
total, 30 documents were included in the systematic review representing 25 unique sets of 
guidance. Most sources of guidance did not explicitly identify an intended audience and 
guidance varied in its relevance to public health. Table 3 presents an overview of all sources 
of guidance included in the review with sources of guidance more or less relevant to public 
health identified as well as those which specifically applied to exploratory studies with a 
randomised design specifically. 
 
INSERT FIGURE 1 HERE  
 
INSERT TABLE 3 HERE 
 
Findings from guidance 
The included guidance reported a wide range of recommendations on the process of 
conducting and reporting exploratory studies. We categorised these into eight themes that 
capture: pre-requisites for conducting an exploratory study, nomenclature, guidance for 
intervention assessment, guidance surrounding the future evaluation study design, adaptive 
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vs rigid designs, progression criteria for exploratory studies, stakeholder involvement and 
reporting. 
Narrative description of themes 
Theme 1: Pre-requisites for conducting an exploratory study  
Where mentioned, pre-requisite activities included determining the evidence base, 
establishing the theoretical basis for the intervention, identifying the intervention 
components as well as modelling of the intervention in order to understand how intervention 
components interact and impact on final outcomes [6, 24-26]. These were often discussed 
ǁithiŶ the ĐoŶteǆt of the M‘C͛s intervention development-evaluation cycle [6, 7, 10, 24-28]. 
Understanding how intervention components interact with various contextual settings [26, 
28, 29], identifying unintended harms [28, 29] as well as potential implementation issues [6, 
7, 28, 30] were also highlighted.  There was an absence of detail in judging when these above 
conditions were met sufficiently for moving onto an exploratory study. 
Theme 2: Nomenclature  
A wide range of terms were used, sometimes interchangeably, to describe exploratory studies 
with the most common being pilot trial/study. Table 4 shows the frequency of the terms used 
in guidance including other terms endorsed.  
Table 4: Frequency of nomenclature used 
Nomenclature Number of sources 
Pilot trial/study 16 
Feasibility trial/study 8 
Feasibility and piloting stage 5 
Pilot and/or feasibility trial/study 5 
Phase II trial/study 3 
Exploratory trial/study 3 
Other terms (external pilot, feasibility studies but not pilot 
studies, non-randomised pilot studies, randomised feasibility 
studies, randomised pilot studies, exploratory pilot study, 
Terms presented once 
or twice across different 
sources of guidance.   
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feasibility RCT, formative study, phase II stage, pilot RCT, 
process  
evaluation with a pilot trial, randomised feasibility trial, 
randomised pilot trial) 
Note: terms are not mutually exclusive 
 
Different terminology did not appear to be consistently associated with specific study 
purposes (see theme 3), as illustrated in Table 3. ͚Pilot-͛ and ͚feasibility-͛ studies were 
sometimes used interchangeably [7, 18, 19, 24-27, 31] while others made distinctions 
between the two according to design features or particular aims [16-18, 29, 32-34]. For 
example some described pilot studies as a smaller version of a future RCT to run in miniature 
[16-18, 29, 32-34], and was sometimes associated with a randomised design [32, 34], but not 
always [17, 18]. In contrast, feasibility studies were used as an umbrella term by Eldridge et al 
with pilot studies representing a subset of feasibility studies [17, 18]: ͞We suggest that 
researchers view feasibility as an overarching concept, with all studies done  in preparation 
for a main study open to being called feasibility studies, and with pilot studies as a subset of 
feasibility studies.͟ ;p.ϭϴͿ[ϭϴ]. 
Feasibility studies could focus on particular intervention and trial design elements [29, 32] 
which may not include randomisation [32, 34]. Internal pilot studies were primarily viewed as 
part of the full trial [18, 32, 35-38] and are therefore not depicted under nomenclature in 
Table 4.  
While no sources explicitly stated that an exploratory study should focus on one area and not 
the other, aims and associated methods of exploratory studies diverged into two separate 
themes. They pertained to either examining the intervention itself or the future evaluation 
design, and are detailed below in themes 3 and 4.  
Theme 3. Guidance for intervention assessment 
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Sources of guidance endorsed exploratory studies having formative purposes (i.e. refining the 
intervention and addressing uncertainties related to intervention implementation [10, 12, 29, 
31, 39]) as well as summative goals (i.e. assessing the potential impact of an intervention or 
its promise [10, 28, 39]).  
Refining the intervention and underlying theory 
Some guidance suggested that changes could be made within exploratory studies to refine 
the intervention and underlying theory [12, 29, 31] and adapt intervention content to a new 
setting [39]. However, guidance was not clear on what constituted minor vs. major changes 
and implications for progression criteria (see Theme 6). When making changes to the 
intervention or underlying theory, some guidance recommended this take place during the 
course of the exploratory study (see Theme 5). Others highlighted the role of using a multi-
arm design to select the contents of the intervention before a full evaluation [10] and to 
assess potential mechanisms of multiple different interventions or intervention components 
[29]. Several sources highlighted the role of qualitative research in optimising or refining an 
intervention, particularly for understanding the components of the logic model [29] and 
surfacing hidden aspects of the intervention important for delivering outcomes [12].  
Intervention implementation   
There was agreement across a wide range of guidance that exploratory studies could explore 
key uncertainties related to intervention implementation, such as acceptability, feasibility or 
practicality. Notably these terms were often ill-defined and used interchangeably. 
Acceptability ǁas ĐoŶsidered iŶ terŵs of reĐipieŶts͛ reaĐtioŶs [17, 18, 29, 32, 39] while others 
were also attentive to feasibility from the perspective of intervention providers, deliverers 
and health professionals [6, 28-30, 34, 39].  Implementation, feasibility, fidelity and 
͚praĐtiĐalitǇ͛ explored the likelihood of being able to deliver in practice what was intended 
[24-26, 30, 39]. These were sometimes referred to as aims within an embedded process 
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evaluation that took place alongside an exploratory study, although the term process 
evaluation was never defined [7, 12, 17, 29, 40].   
Qualitative research was encouraged for assessment of intervention acceptability [20] or for 
implementation (e.g. via non-participant observation [12]). Caution was recommended with 
regards to focus groups where there is a risk of masking divergent views [12]. Others 
recommended quantitative surveys to examine retention rates and reasons for dropout [17, 
30]. Furthermore, several sources emphasised the importance of testing implementation in a 
range of contexts [12, 29, 39, 41] - especially in less socioeconomically advantaged groups, to 
examine the risk of widening health inequalities [29, 39].  
One source of guidance considered whether randomisation was required for assessing 
intervention acceptability, believing this to be unnecessary but also suggesting it could 
͞poteŶtiallǇ depeŶd oŶ prefereŶĐe aŵoŶg iŶterǀeŶtioŶs offered iŶ the ŵaiŶ trial͟ ([20]; page 
9). Thus issues of intervention acceptability, particularly within multi-arm trials, may relate to 
clinical equipoise and acceptability of randomisation procedures among participants [30].    
Appropriateness of assessing intervention impact  
Several sources of guidance discussed the need to understand the impact of the intervention, 
including harms, benefits or unintended consequences [12, 17, 28, 29, 39]. Much of the 
guidance focused on statistical tests of effectiveness with disagreement on the soundness of 
this aim, although qualitative methods were also recommended [12, 42]. Some condemned 
statistically testing for effectiveness [17, 19, 29, 32, 41], as such studies are often 
underpowered, hence leading to imprecise and potentially misleading estimates of effect 
sizes [17, 19].  Others argued that an estimate of likely effect size could evidence the 
intervention was working as intended and not having serious unintended harms [28] and thus 
be used to calculate the power for the full trial [10]. Later guidance from the MRC is more 
ambiguous than earlier guidance, stating that estimates should be interpreted with caution, 
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ǁhile siŵultaŶeouslǇ statiŶg ͞safe͟ assuŵptioŶs of effeĐt sizes as a pre-requisite before 
continuing to a full evaluation [7]. NIHR guidance, which distinguished between pilot and 
feasibility studies, supported the assessment of a primary outcome in pilot studies, although 
it is unclear whether this is suggesting that a pilot should involve an initial test of changes in 
the primary outcome, or simply that the primary outcome should be measured in the same 
way as it would be in a full evaluation. By contrast, for ͚feasiďilitǇ studies͛, it iŶdiĐated that aŶ 
aim may include designing an outcome measure to be used in a full evaluation.   
Others made the case for identifying evidence of potential effectiveness, including use of 
interim or surrogate endpoints [17, 41], defiŶed as:͞…variables on the causal pathway of what 
might eventually be the primary outcome in the future definitive RCT, or outcomes at early 
time points, in order to assess the potential for the intervention to affect likely outcomes in 
the future definitive RCT…͟ [17] (p. 14).  
Randomisation was implied as a design feature of exploratory studies when estimating an 
effect size estimate of the intervention as it maximised the likelihood that observed 
differences are due to intervention [6, 39], with guidance mostly written from a starting 
assumption that full evaluation will take the form of an RCT, and guidance focused less on 
exploratory studies for quasi-experimental or other designs. For studies that aim to assess 
potential effectiveness using a surrogate or interim outcome, using a standard sample size 
calculation was recommended to ensure adequate power, although it was noted that this aim 
is rare in exploratory studies [17].  
Theme 4: Guidance surrounding the future evaluation design 
Sources consistently advocated assessing the feasibility of study procedures or estimating 
parameters of the future evaluation. Recommendations are detailed below.  
Assessing feasibility of the future evaluation design  
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Assessing feasibility of future evaluation procedures was commonly recommended [7, 12, 17, 
28, 30, 32-34, 37, 41] to avert problems that could undermine the conduct or acceptability of 
future evaluation [12, 28, 30]. A wide range of procedures were suggested as requiring 
assessments of feasibility including: data collection [19, 30, 34, 36, 41], participant retention 
strategies [10], randomisation [10, 17, 19, 30, 34, 36, 38, 41], recruitment methods [10, 30, 
32, 34, 35, 38, 41], running the full trial protocol [19, 30, 36]; the willingness of participants to 
be randomised [30, 32] and issues of contamination [30]. There was disagreement concerning 
the appropriateness of assessing blinding in exploratory studies [17, 30, 34], with one source 
noting double blinding is difficult when participants are assisted in changing their behaviour; 
although assessing single-blinding may be possible [30].  
Qualitative [12, 30, 34], quantitative [34] as well as mixed methods [17] were endorsed for 
assessing these processes. Reflecting the tendency for guidance of exploratory studies to be 
limited to studies in preparation for RCTs, discussion of the role of randomisation at the 
exploratory study stage featured heavily in guidance.  Randomisation within an exploratory 
study was considered necessary for examining: feasibility of recruitment, consent to 
randomisation, retention, contamination or maintenance of blinding in the control and 
intervention groups, randomisation procedures and whether all the components of a protocol 
can work together; although randomisation was not deemed necessary to assess outcome 
burden and participant eligibility [20, 30, 34]. While there was consensus about what issues 
could be assessed through randomisation, sources disagreed on whether randomisation 
should always precede a future evaluation study, even if that future study is to be an RCT. 
Contention seemed to be linked to variation in nomenclature and associated aims. For 
example, some defined pilot study as a study run in miniature to test how all its components 
work together, thereby dictating a randomised design [32, 34]. Yet for feasibility studies, 
randomisation was only necessary if it reduced the uncertainties in estimating parameters for 
the future evaluation [32, 34]. Similarly, other guidance highlighted an exploratory study 
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(irrespective of nomenclature) should address the main uncertainties, and thus may not 
depend on randomisation [12, 18].  
Estimating parameters of the future evaluation design  
A number of sources recommended exploratory studies should inform the parameters of the 
future evaluation design. Areas for investigation included: estimating samples sizes required 
for the future evaluation (e.g. measuring outcomes [32, 35]; power calculations [10]; derive 
effect size estimates [17, 28, 39]; estimating target differences [35, 43]; deciding what 
outcomes to measure and how [6, 19, 30, 36]; assessing quality of measures (e.g. for 
reliability/ validity/ feasibility/ sensitivity [17, 19, 30]; identification of control group [6, 10]; 
recruitment, consent and retention rates [7, 10, 19, 30, 32, 34, 36]; and information on the 
cost of the future evaluation design [6, 30, 36].  
While qualitative methods were deemed useful for selecting outcomes and their suitable 
measures [12], most guidance concentrated on quantitative methods for estimating future 
evaluation sample sizes. This was contentious due to the potential to over- or under-estimate 
sample sizes required in a future evaluation due to the lack of precision of estimates from a 
small pilot [19, 30, 41]. Estimating sample sizes from effect size estimates in an exploratory 
study was nevertheless argued by some to be useful if there was scant literature and the 
exploratory study used the same design and outcome as the future evaluation [30, 39]. 
Cluster RCTs, which are common in public health interventions, were specifically earmarked 
as unsuitable for estimating parameters for sample size calculations (e.g. intra-cluster 
correlation coefficients) as well as recruitment and follow-up rates without additional 
information from other resources, because a large number of clusters and individual 
participants would be required [41]. Others referred to ͚rules of thuŵď͛ when determining 
sample sizes in an exploratory study with numbers varying between 10-75 participants per 
trial arm in individually randomised studies [17, 30, 36]. Several also recommended the need 
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to consider a desired meaningful difference in the health outcomes from a future evaluation 
and the appropriate sample size needed to detect this, rather than conducting sample size 
calculations using estimates of likely effect size from pilot data [30, 35, 38, 43]. 
A randomised design was deemed unnecessary for estimating costs or selecting outcomes, 
although was valued for estimating recruitment and retention rates for intervention and 
control groups [20, 34]. Where guidance indicated the estimation of an effect size 
appropriate to inform the sample size for a future evaluation, a randomised design was 
deemed necessary [6, 39]. 
Theme 5: Flexible vs. fixed design  
Sources stated that exploratory studies could employ a rigid or flexible design. With the latter, 
the design can change during the course of the study, which is useful for making changes to 
the intervention, as well as the future evaluation design [10, 12, 28, 31]. Here, qualitative 
data can be analysed as it is collected, shaping the exploratory study process, for instance 
sampling of subsequent data collection points [12], and clarifying implications for intervention 
effectiveness [31].  
In contrast, fixed exploratory studies were encouraged when primarily investigating the 
future evaluation parameters and processes [10]. It may be that the nomenclature used in 
some guidance (e.g. pilot studies that are described as miniature versions of the evaluation) is 
suggesting a distinction between more flexible vs more stringent designs. In some guidance it 
was not mentioned whether changes should be made during the course of an exploratory 
study or afterwards, in order to get the best possible design for the future evaluation [17, 20, 
28].  
Theme 6: Progression Criteria to a future evaluation study 
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Little guidance was provided on what should be considered when formulating progression 
criteria for continuing onto a future evaluation study. Some focussed on the relevant 
uncertainties of feasibility [32, 39], while others highlight specific items concerning cost-
effectiveness [7], refining causal hypotheses to be tested in a future evaluation [29] and 
meeting recruitment targets [19, 34]. As discussed in themes 3 and 4, statistically testing for 
effectiveness and using effect sizes for power calculations was cautioned by some, and so 
criteria based on effect sizes were not specified [38].  
Greater discussion was devoted to how to weight evidence from an exploratory study that 
addressed multiple aims and used different methods. Some explicitly stated progression 
criteria should not be judged as strict thresholds but as guidelines using, for example, a traffic 
lights system with varying levels of acceptability [17, 41]. Others highlighted a realist 
approach, moving away from binary indicators to focusiŶg oŶ ͞ǁhat is feasiďle aŶd aĐĐeptaďle 
for ǁhoŵ aŶd uŶder ǁhat ĐirĐuŵstaŶĐes͟ [29]. In light of the difficulties surrounding 
interpretation of effect estimates, several sources recommended qualitative findings from 
exploratory studies should be more influential than quantitative findings [12, 38]. 
Interestingly, there was ambiguity regarding progression when exploratory findings indicated 
substantial changes to the intervention or evaluation design. Sources considering this issue 
suggested that if ͞eǆteŶsiǀe ĐhaŶges͟ or ͞ŵajor ŵodifiĐatioŶs͟ are ŵade to either (note they 
did not specify what qualified as such), researchers should return to the exploratory [20, 30] 
or intervention development phases [12]  
͞Alternatively, at the feasibility phase, researchers may identify fundamental problems with 
the intervention or trial conduct and return to the development phase rather than proceed to 
a full trial.͟ ;p. ϭͿ [ϭϮ]. 
As described previously, however, the threshold at which changes are determined to be 
͞ŵajor͟ reŵaiŶed aŵďiguous. While updated MRC guidance [7] moved to a more iterative 
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model, accepting that movement back between feasibility/piloting and intervention 
development may sometimes be needed, there was no guidance on under what conditions 
movement between these two stages should take place. 
Theme 7. Stakeholder involvement 
 Several sources recommended a range of stakeholders (e.g. intervention providers, 
intervention recipients, public representatives as well as practitioners who might use the 
evidence produced by the full trial) be involved in the planning and running of the exploratory 
study to ensure exploratory studies reflect the realities of intervention setting [12, 27, 31, 32, 
39, 40]. In particular, community-based participatory approaches were recommended [12, 
39]. While many highlighted the value of stakeholders on Trial Steering Committees and other 
similar study groups [12, 27, 40], some warned about equipoise between researchers and 
stakeholders [12, 40] and also cautioned against researchers conflating stakeholder 
involvement with qualitative research [12].   
͞Although patient and public representatives on research teams can provide helpful feedback 
on the intervention, this does not constitute qualitative research and may not result in 
sufficiently robust data to inform the appropriate development of the intervention.͟ ;p. ϴͿ 
[12]. 
Theme 8. Reporting of exploratory studies 
Detailed recommendations for reporting exploratory studies were recently provided in new 
Consolidated Standards of Reporting Trials (CONSORT) guidance by Eldridge & Chan et al [17]. 
In addition to this, recurrent points were brought up by other sources of guidance. Most 
notably, it was recommended exploratory studies be published in peer-reviewed journals as 
this can provide useful information to other researchers on what has been done, what did not 
work and what might be most appropriate [12, 30]. An exploratory study may also result in 
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multiple publications, but should provide reference to other work carried out in the same 
exploratory study [12, 17]. Several sources of guidance also highlight that exploratory studies 
should be appropriately labelled in the title/abstract to enable easy identification; however 
the nomenclature suggested varied depending on guidance [12, 17, 18]. 
DISCUSSION  
While exploratory studies - carried out to inform decisions about whether and how to 
proceed with an effectiveness study [17,18] - are increasingly recognised as important in the 
efficient evaluation of complex public health interventions, our findings suggest that this area 
remains in need of consistent standards to inform practice. At present, there are multiple 
definitions of exploratory studies, a lack of consensus on a number of key issues, and a 
paucity of detailed guidance how to approach the main uncertainties such studies aim to 
address prior to proceeding to a full evaluation.  
 
Existing guidance commonly focuses almost exclusively on testing methodological parameters 
[33], such as recruitment and retention, although in practice, it is unusual for such studies not 
to also focus on the feasibility of the intervention itself. Where intervention feasibility is 
discussed, there is limited guidance on when an intervention is ͞readǇ͟ for aŶ eǆploratorǇ 
study, and a lack of demarcation between intervention development and pre-evaluation work 
to understand feasibility. Some guidance recognised that an intervention continues to 
develop throughout an exploratory study, with distinctions made between 
͞optiŵisatioŶ/refiŶeŵeŶt͟ ;i.e. ŵiŶor refiŶeŵeŶts to the iŶterǀeŶtioŶͿ ǀs. ͞ŵajor ĐhaŶges͟.  
However, the point at which changes become so substantial that movement back toward 
intervention development rather than forward to a full evaluation remains ambiguous. 
Consistent with past reviews which adopted a narrower focus on studies with randomised 
designs [20] or in preparation for a randomised trial [18, 36] and limited searches of guidance 
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in medical journals [16, 36], terms to describe exploratory studies were inconsistent, with a 
distinction for example sometimes made between pilot and feasibility studies, though with 
others using these terms interchangeably.  
 
The review identifies a number of key areas of disagreement or limited guidance in regards to 
the critical aims of exploratory studies and addressing uncertainties which might undermine a 
future evaluation, and how these aims should be achieved. There was much disagreement for 
example on whether exploratory studies should include a preliminary assessment of 
intervention effects to inform decisions on progression to a full evaluation, and the 
appropriateness of using estimates of effect from underpowered data (from non-
representative samples and a study based on a not fully optimised version of the 
intervention) to power a future evaluation study. Most guidance focused purely on studies in 
preparation for RCTs; nevertheless, guidance varied on whether randomisation was a 
necessary feature of the exploratory study, even where a future evaluation study was an RCT. 
Guidance was often difficult to assess regarding its applicability to public health research, 
with many sources focusing on literature and practice primarily from clinical research, and 
limited consideration of the transferability of these problems and proposed solutions to 
complex social interventions, such as those in public health.  Progression criteria were 
highlighted as important by some as a means of preventing biased post-hoc cases for 
continuation. However, there was a lack of guidance on how to devise progression criteria 
and processes for assessing whether these had been sufficiently met.  Where they had not 
been met, there was a lack of guidance on how to decide whether the exploratory study had 
generated sufficient insight about uncertainties that the expense of a further feasibility study 
would not be justified prior to large scale evaluation. 
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Although our review included a broad focus on guidance of exploratory studies from 
published and grey literature, and moved beyond a focus on studies conducted in preparation 
for an RCT specifically, a number of limitations should be noted. Guidance from other area of 
social intervention research where challenges may be similar to those in public health (e.g. 
education, social work and business) may not have been captured by our search strategy. We 
found few worked examples of exploratory studies in public health that provided substantial 
information from learned experience and practice. Hence, the review drew largely on 
recommendations from funding organisations, or relatively abstract guidance from teams of 
researchers, with fewer clear examples of how these recommendations are grounded in 
experience from the conduct of such studies. As such, it should be acknowledged that these 
documents represent one element within a complex system of research production and may 
not necessarily fully reflect what is taking place in the conduct of exploratory studies. Finally, 
treating sources of guidance as independent from each other does not reflect how some 
recommendations developed over time (see for example 17-19, 36, 41). 
 
Conclusion  
There is inconsistent guidance, and for some key issues a lack of guidance, for exploratory 
studies of complex public health interventions. As this lack of guidance for researchers in 
public health continues, the implications and consequences could be far reaching [44]. It is 
unclear how researchers use existing guidance to shape decision-making in the conduct of 
exploratory studies, and in doing so, how they adjudicate between various conflicting 
perspectives. This systematic review has aimed largely to identify areas of agreement and 
disagreement as a starting point in bringing order to this somewhat chaotic field of work. 
Following this systematic review, our next step is to conduct an audit of published public 
health exploratory studies in peer-reviewed journals, to assess current practice and how this 
reflects the reviewed guidance. As part of a wider study, funded by the MRC/NIHR 
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Methodology Research Programme to develop GUidance for Exploratory STudies of complex 
public health interventions (GUEST)[44], the review has informed a Delphi survey of 
researchers, funders and publishers of public health research. In turn, this will contribute to a 
consensus meeting which aims to reach greater unanimity on the aims of exploratory studies, 
and how these can most efficiently address uncertainties which may undermine a full-scale 
evaluation to inform new guidance in this area.  
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